GlaxoSmithKline Consumer Healthcare Pakistan Limited announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was PKR 3,913.657 million compared to PKR 3,938.458 million a year ago. Operating income was PKR 402.583 million compared to PKR 522.986 million a year ago. Net income was PKR 279.524 million compared to PKR 382.494 million a year ago. Basic earnings per share was PKR 2.39 compared to PKR 3.27 a year ago. For the nine months, sales was PKR 11,812.260 million compared to PKR 10,856.290 million a year ago. Operating income was PKR 1,401.772 million compared to PKR 1,391.768 million a year ago. Net income was PKR 888.342 million compared to PKR 845.952 million a year ago. Basic earnings per share was PKR 7.59 compared to PKR 7.23 a year ago.